<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Genmab A/S

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Genmab A/S

    Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer. Founded in 1999, the company has two approved antibodies, a broad clinical and pre-clinical product pipeline and three proprietary next generation antibody technologies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $1,100,000,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Jan G. J. van de Winkel, Ph.D.
    • FOUNDED
      1999
    • EMPLOYEES
      251-500
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Biolase, Inc.

    Biolase, Inc.

    BIOLASE, Inc. is a medical device company and global market leader in the manufact...

    BIOLASE, Inc. is a medical device company and g...

    Filing Type:    PU
    Acasti Pharma, Inc.

    Acasti Pharma, Inc.

    Acasti is a biopharmaceutical innovator focused on the research, development and c...

    Acasti is a biopharmaceutical innovator focused...

    Filing Type:    PU
    BelleIQ, Inc.

    BelleIQ, Inc.

    BelleIQ operates ALLIES, an online marketplace selling health & wellness products ...

    BelleIQ operates ALLIES, an online marketplace ...

    Amount Raised:    $0
    Fundraising Status:    EC
    Filing Type:    CF
    Biogen Inc.

    Biogen Inc.

    At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers...

    At Biogen, our mission is clear: we are pioneer...

    Filing Type:    PU
    AVROBIO, Inc.

    AVROBIO, Inc.

    AVROBIO, Inc., a leader in lentiviral-based gene therapies, is a clinical stage co...

    AVROBIO, Inc., a leader in lentiviral-based gen...

    Filing Type:    PU
    IDEXX Laboratories, Inc.

    IDEXX Laboratories, Inc.

    IDEXX Laboratories, Inc. is a member of the S&P 500ÂŽ Index and is a leader in pet...

    IDEXX Laboratories, Inc. is a member of the S&P...

    Filing Type:    PU
    IGM Biosciences, Inc.

    IGM Biosciences, Inc.

    Headquartered in Mountain View, California, IGM Biosciences is a biotechnology com...

    Headquartered in Mountain View, California, IGM...

    Filing Type:    PU
    Immunomedics, Inc.

    Immunomedics, Inc.

    Immunomedics is a clinical-stage biopharmaceutical company developing monoclonal a...

    Immunomedics is a clinical-stage biopharmaceuti...

    Filing Type:    PU
    Five Prime Therapeutics, Inc.

    Five Prime Therapeutics, Inc.

    Five Prime Therapeutics, Inc. discovers and develops innovative therapeutics to im...

    Five Prime Therapeutics, Inc. discovers and dev...

    Filing Type:    PU
    Genocea Biosciences, Inc.

    Genocea Biosciences, Inc.

    Genocea is a biopharmaceutical company developing personalized cancer immunotherap...

    Genocea is a biopharmaceutical company developi...

    Filing Type:    PU
    Heron Therapeutics, Inc.

    Heron Therapeutics, Inc.

    Our mission is to improve the lives of patients by developing novel, best-in-class...

    Our mission is to improve the lives of patients...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.